(Reuters) - The company's shares were up 3.8 percent at $63.99 in
midday trading, after having risen as high as $64.90, earlier
in the session on the New York Stock Exchange.
"Cytec is poised to benefit from lower fixed costs,
selective pricing increases, along with its aggressive cost
savings and production rationalization initiatives," Goldman
Sachs analyst Robert Koort said in a note to investors.
Read more at Reuters.com Mergers News
midday trading, after having risen as high as $64.90, earlier
in the session on the New York Stock Exchange.
"Cytec is poised to benefit from lower fixed costs,
selective pricing increases, along with its aggressive cost
savings and production rationalization initiatives," Goldman
Sachs analyst Robert Koort said in a note to investors.
Read more at Reuters.com Mergers News
No comments:
Post a Comment